Search results for " industry"
Article
The Need for Advanced Process Modeling for New Therapeutic Biologics
Further, the industry lacks “user-friendly tools” and clear workflows for setting up specific process models, and existing process control systems do not implement model-based approaches (2).
…
Article
A Diverse Landscape of Patent Issues Seen in the US, UK, and the EU
Combination drug-devices
BioPharm: What challenges must the industry resolve in protecting IP for combination therapies (drug/device)?
Royle (Taylor Wessing): Drug/device manufacturers suffe…
Article
Optimizing Drug Safety and Efficacy of Complex Next-Generation Biologics
In recent years, the global biopharma industry has seen a rapidly advancing trend toward biotherapeutics or ‘biologic’ drugs—drugs that are produced from living organisms or contain components of li…
Article
Methods Accelerate Biosimilar Analysis
Conclusion
The biosimilar industry in the United States has been evolving more slowly than anticipated and drug competition that would have resulted in lower costs for biologics has yet be realize…
Article
Tools and Processes for Mature and Emerging Therapies
…requirements for emerging cell therapies and gene therapies may require revolutionary changes to the industry’s approach to making drugs.
In April 2019, at the INTERPHEX trade show in New York Ci…
Article
Real-Time Characterization of Biotherapeutics and Comparability of Biosimilars
The biopharmaceutical industry faces an increasing demand to accelerate process development while saving on cost and time. A possible solution to alleviate this is by using high-throughput potential t…
Article
Biopharmaceutical Process Development: 2018 Lessons and 2019 Predictions
Clearly, industry members (including Process Development Forum readers) are extremely interested in learning about what these solutions have to offer, but the adoption of single-use systems is still c…
Resource
Affinity, Stockholm, Sweden
This meeting has a long tradition, where scientists and engineers from academia and industry meet to exchange knowledge in the field of affinity technology, molecular recognition and its application i…
Resource
Plasma Product Biotechnology Conference
…ory, pathogen safety, clinical development and technical innovations, and will chaired by recognised industry experts with broad plasma products experience and insight into their individual disciplin…
Article
Recent Advances in the Use of Exoglycosidases to Improve Structural Profiling of N-glycans from Biologic Drugs
New problems, new solutions
An ongoing pharmaceutical industry trend has been the adoption of faster and more sensitive glycoanalytical workflows. Over the past few years, several commercial suppl…